These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25264415)

  • 21. Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew.
    Roose R; Fuentes L; Cheema M
    Subst Use Misuse; 2012 Aug; 47(10):1117-24. PubMed ID: 22587811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Elias AM; Pepin MJ; Brown JN
    J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review.
    Ghabrash MF; Bahremand A; Veilleux M; Blais-Normandin G; Chicoine G; Sutra-Cole C; Kaur N; Ziegler D; Dubreucq S; Juteau LC; Lestage L; Jutras-Aswad D
    J Dual Diagn; 2020; 16(2):191-207. PubMed ID: 32089124
    [No Abstract]   [Full Text] [Related]  

  • 25. Case Report: Buprenorphine Induction Using Transdermal Buprenorphine in a Veteran With Opioid Use Disorder and Psychosis, Managing Precipitated Withdrawal.
    Kinasz KR; Herbst ED; Kalapatapu RK
    Mil Med; 2020 Sep; 185(9-10):e1872-e1875. PubMed ID: 32314788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A; Gonzalez G
    Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine Therapy for Opioid Use Disorder.
    Zoorob R; Kowalchuk A; Mejia de Grubb M
    Am Fam Physician; 2018 Mar; 97(5):313-320. PubMed ID: 29671504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
    Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
    Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review.
    Sritapan Y; Clifford S; Bautista A
    Balkan Med J; 2020 Aug; 37(5):247-252. PubMed ID: 32407063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversation with Walter Ling.
    Ling W
    Addiction; 2015 Jan; 110(1):14-8. PubMed ID: 25322681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between dissociative symptoms and the medications used in the treatment of opioid use disorder.
    Gainer DM; Crawford TN; Fischer KB; Wright MD
    J Subst Abuse Treat; 2021 Feb; 121():108195. PubMed ID: 33357605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 38. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy.
    Pajusco B; Chiamulera C; Quaglio G; Moro L; Casari R; Amen G; Faccini M; Lugoboni F
    Int J Environ Res Public Health; 2012 Mar; 9(3):932-42. PubMed ID: 22690174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
    Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO
    J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study.
    Dennis BB; Akhtar D; Cholankeril G; Kim D; Sanger N; Hillmer A; Chawar C; D'Elia A; Panesar B; Worster A; Marsh DC; Thabane L; Samaan Z; Ahmed A
    Drug Alcohol Depend; 2020 Apr; 209():107917. PubMed ID: 32088589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.